QM/MM refinement and analysis of protein bound retinoic acid
暂无分享,去创建一个
[1] Ulf Ryde,et al. Quantum refinement of [FeFe] hydrogenase indicates a dithiomethylamine ligand. , 2010, Journal of the American Chemical Society.
[2] M. Gilson,et al. Calculation of protein-ligand binding affinities. , 2007, Annual review of biophysics and biomolecular structure.
[3] Gerhard Klebe,et al. A fast and efficient method to generate biologically relevant conformations , 1994, J. Comput. Aided Mol. Des..
[4] Kristina Nilsson,et al. Quantum refinement - a combination of quantum chemistry and protein crystallography. , 2003 .
[5] Xiao He,et al. Conformational variability of benzamidinium-based inhibitors. , 2009, Journal of the American Chemical Society.
[6] D. Moras,et al. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. , 2001, Journal of molecular biology.
[7] P. Harbury,et al. Design of protein-ligand binding based on the molecular-mechanics energy model. , 2008, Journal of molecular biology.
[8] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[9] Kristina Nilsson,et al. Quantum chemistry can locally improve protein crystal structures. , 2003, Journal of the American Chemical Society.
[10] R. Pattanayek,et al. Protein and ligand adaptation in a retinoic acid binding protein , 1999, Protein science : a publication of the Protein Society.
[11] A Coda,et al. Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. , 1995, Science.
[12] Pierre Chambon,et al. A human retinoic acid receptor which belongs to the family of nuclear receptors , 1987, Nature.
[13] Babak Borhan,et al. Protein design: reengineering cellular retinoic acid binding protein II into a rhodopsin protein mimic. , 2007, Journal of the American Chemical Society.
[14] L. D. De Luca,et al. Therapeutic potential of "rexinoids" in cancer prevention and treatment. , 2009, Cancer research.
[15] Jean-Paul Renaud,et al. All-trans retinoic acid is a ligand for the orphan nuclear receptor RORβ , 2003, Nature Structural Biology.
[16] Xue Li,et al. Accurate assessment of the strain energy in a protein‐bound drug using QM/MM X‐ray refinement and converged quantum chemistry , 2011, J. Comput. Chem..
[17] Kenneth M Merz,et al. Critical assessment of quantum mechanics based energy restraints in protein crystal structure refinement , 2006, Protein science : a publication of the Protein Society.
[18] T J Oldfield,et al. X-LIGAND: an application for the automated addition of flexible ligands into electron density. , 2001, Acta crystallographica. Section D, Biological crystallography.
[19] M. Gilson,et al. Ligand configurational entropy and protein binding , 2007, Proceedings of the National Academy of Sciences.
[20] A. Budhu,et al. Direct Channeling of Retinoic Acid between Cellular Retinoic Acid-Binding Protein II and Retinoic Acid Receptor Sensitizes Mammary Carcinoma Cells to Retinoic Acid-Induced Growth Arrest , 2002, Molecular and Cellular Biology.
[21] Steven W Muchmore,et al. Crystallography, NMR and virtual screening: integrated tools for drug discovery. , 2003, Current opinion in drug discovery & development.
[22] V S Lamzin,et al. Modelling bound ligands in protein crystal structures. , 2004, Acta crystallographica. Section D, Biological crystallography.
[23] Marcel L Verdonk,et al. Automated Protein–Ligand Crystallography for Structure‐Based Drug Design , 2006, ChemMedChem.
[24] Giuseppe Zanotti,et al. Crystallographic studies on complexes between retinoids and plasma retinol-binding protein. , 1994 .
[25] Warren J. Hehre,et al. Practical strategies for electronic structure calculations , 1995 .
[26] Jean-Paul Renaud,et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.
[27] Lindsay Sawyer,et al. The ligand-binding site of bovine beta-lactoglobulin: evidence for a function? , 2002, Journal of molecular biology.
[28] Julian Tirado-Rives,et al. Contribution of conformer focusing to the uncertainty in predicting free energies for protein-ligand binding. , 2006, Journal of medicinal chemistry.
[29] Kristina Nilsson,et al. Quantum refinement — a method to determine protonation and oxidation states of metal sites in protein crystal structures , 2003 .
[30] M. Newcomer,et al. X-ray crystallographic identification of a protein-binding site for both all-trans- and 9-cis-retinoic acid. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] Warren J. Hehre,et al. AB INITIO Molecular Orbital Theory , 1986 .
[32] Eamonn F. Healy,et al. Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .
[33] Jonas Boström,et al. Reproducing the conformations of protein-bound ligands: A critical evaluation of several popular conformational searching tools , 2001, J. Comput. Aided Mol. Des..
[34] Gerhard Klebe,et al. What Can We Learn from Molecular Recognition in Protein–Ligand Complexes for the Design of New Drugs? , 1996 .
[35] Babak Borhan,et al. Structural analysis of site-directed mutants of cellular retinoic acid-binding protein II addresses the relationship between structural integrity and ligand binding. , 2008, Acta crystallographica. Section D, Biological crystallography.
[36] Paul Tempst,et al. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR7 and RXRa , 1994 .
[37] Kristina Nilsson,et al. Quantum chemical geometry optimizations in proteins using crystallographic raw data , 2002, J. Comput. Chem..
[38] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[39] Gerard J Kleywegt,et al. Pound-wise but penny-foolish: How well do micromolecules fare in macromolecular refinement? , 2003, Structure.
[40] Eric F. Johnson,et al. Determinants of Cytochrome P450 2C8 Substrate Binding , 2008, Journal of Biological Chemistry.
[41] Richard A Friesner,et al. Modeling Polarization in Proteins and Protein-ligand Complexes: Methods and Preliminary Results. , 2005, Advances in protein chemistry.
[42] V. Vivat-Hannah,et al. Selective retinoids and rexinoids in cancer therapy and chemoprevention. , 2002, Drug discovery today.
[43] K. Merz,et al. Large-scale validation of a quantum mechanics based scoring function: predicting the binding affinity and the binding mode of a diverse set of protein-ligand complexes. , 2005, Journal of medicinal chemistry.
[44] Kenneth M Merz,et al. QM/MM X-ray refinement of zinc metalloenzymes. , 2010, Journal of inorganic biochemistry.
[45] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[46] P. Charifson,et al. Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding. , 2004, Journal of medicinal chemistry.
[47] Gerard J Kleywegt,et al. Application and limitations of X-ray crystallographic data in structure-based ligand and drug design. , 2003, Angewandte Chemie.
[48] G. Malpeli,et al. Crystal structure of the transthyretin--retinoic-acid complex. , 1995, European journal of biochemistry.
[49] Gregor Eichele,et al. Identification and spatial distribution of retinoids in the developing chick limb bud , 1987, Nature.
[50] Gerhard Klebe,et al. Toward a more efficient handling of conformational flexibility in computer-assisted modelling of drug molecules , 1995 .
[51] M. Lambert,et al. Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. , 2000, Genes & development.
[52] Stefan Schmitt,et al. Do structurally similar ligands bind in a similar fashion? , 2006, Journal of medicinal chemistry.
[53] K. Dill,et al. Predicting absolute ligand binding free energies to a simple model site. , 2007, Journal of molecular biology.
[54] Philippe Kastner,et al. Nonsteroid nuclear receptors: What Are genetic studies telling us about their role in real life? , 1995, Cell.
[55] P Chambon,et al. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[56] Babak Borhan,et al. The structure of Apo-wild-type cellular retinoic acid binding protein II at 1.4 A and its relationship to ligand binding and nuclear translocation. , 2006, Journal of molecular biology.
[57] A. Brunger. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. , 1992 .
[58] Kenneth M Merz,et al. Refinement of protein crystal structures using energy restraints derived from linear-scaling quantum mechanics. , 2005, Acta crystallographica. Section D, Biological crystallography.
[59] D. Moras,et al. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor. , 2000, Journal of molecular biology.
[60] Peter A. Kollman,et al. Calculation of molecular geometries, relative conformational energies, dipole moments, and molecular electrostatic potential fitted charges of small organic molecules of biochemical interest by density functional theory , 1995, J. Comput. Chem..
[61] Cen Gao,et al. Accounting for ligand conformational restriction in calculations of protein-ligand binding affinities. , 2010, Biophysical journal.
[62] T. A. Jones,et al. Crystal structures of cellular retinoic acid binding proteins I and II in complex with all-trans-retinoic acid and a synthetic retinoid. , 1995, Structure.
[63] K. Umesono,et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[64] Ilme Schlichting,et al. Crystal structures of substrate-free and retinoic acid-bound cyanobacterial cytochrome P450 CYP120A1. , 2008, Biochemistry.